Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The 4th European School of Hematology Acute Leukemia (ESH AL) Congress took place on March 1-3, 2024, in Stockholm, Sweden. This event brought experts from around the world together to discuss the diagnosis and treatment of acute leukemia.
View all videos

ESH AL 2024

The 4th European School of Hematology Acute Leukemia (ESH AL) Congress
01–03 March 2024 | Stockholm, Sweden

ESH AL 2024

The 4th European School of Hematology Acute Leukemia (ESH AL) Congress
01–03 March 2024 | Stockholm, Sweden
The 4th European School of Hematology Acute Leukemia (ESH AL) Congress took place on March 1-3, 2024, in Stockholm, Sweden. This event brought experts from around the world together to discuss the diagnosis and treatment of acute leukemia.
View all videos

Latest Videos

View all videos
1:36
The future of frontline treatment in ALL: immunotherapy
Mark Litzow • 27 Feb 2024
2:15
The advantage of early blinatumomab treatment over chemotherapy in ALL
Mark Litzow • 27 Feb 2024
3:54
A case study from the ECOG-E1910 trial: early blinatumomab treatment in ALL
Mark Litzow • 27 Feb 2024
2:18
The current landscape of treatment for BPDCN
Andrew Lane • 26 Feb 2024

ALL

View all
1:36
The future of frontline treatment in ALL: immunotherapy
Mark Litzow • 27 Feb 2024
2:15
The advantage of early blinatumomab treatment over chemotherapy in ALL
Mark Litzow • 27 Feb 2024

BPDCN

View all
2:18
The current landscape of treatment for BPDCN
Andrew Lane • 26 Feb 2024
1:30
Recent advancements in BPDCN: diagnostic criteria, pathophysiology, and treatment
Andrew Lane • 26 Feb 2024
The content of VJHemOnc is intended for healthcare professionals